eFFECTOR Therapeutics, Inc.
EFTR
$0.0002
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.24% | -9.96% | 0.73% | 16.48% | -8.14% |
| Total Depreciation and Amortization | -6.67% | 15.38% | -3.70% | -3.57% | 3.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.15% | 6.04% | -11.38% | 3.34% | -14.17% |
| Change in Net Operating Assets | -80.27% | 566.03% | 63.62% | -218.35% | 7.46% |
| Cash from Operations | -30.76% | 28.23% | 9.74% | -12.50% | -12.64% |
| Capital Expenditure | -- | -2,600.00% | 92.86% | -115.38% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -170.23% | 570.47% | -23.74% | -117.10% | 148.69% |
| Cash from Investing | -170.66% | 567.15% | -21.66% | -117.44% | 149.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 142.07% | 1,686.26% | -97.65% | 6,772.64% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 132.97% | 1,686.26% | -97.65% | 6,772.64% | 672.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.33% | 201.73% | -311.81% | 174.91% | 150.14% |